4//SEC Filing
ALTMAN MICHAEL SETH 4
Accession 0001062993-22-015188
CIK 0001808805other
Filed
Jun 16, 8:00 PM ET
Accepted
Jun 17, 5:43 PM ET
Size
5.4 KB
Accession
0001062993-22-015188
Insider Transaction Report
Form 4
ALTMAN MICHAEL SETH
DirectorChief Financial Officer10% Owner
Transactions
- Award
Stock Option (Right to Buy)
2022-06-15+86,467→ 86,467 totalExercise: $2.70Exp: 2032-06-15→ Common Stock (86,467 underlying)
Footnotes (1)
- [F1]Subject to the reporting person's continuous status as a "Service Provider" (as defined in the Issuer's 2021 Equity Incentive Plan) through each vesting date, the shares subject to the Option shall vest on a monthly basis for twelve consecutive months, on the same day of the month as the Grant Date. The Grant Date was June 15, 2022.
Issuer
Nautilus Biotechnology, Inc.
CIK 0001808805
Entity typeother
Related Parties
1- filerCIK 0001746738
Filing Metadata
- Form type
- 4
- Filed
- Jun 16, 8:00 PM ET
- Accepted
- Jun 17, 5:43 PM ET
- Size
- 5.4 KB